In a filing, Medifast Inc revealed its Chairman & CEO Chard Daniel R acquired Company’s shares for reported $5003.0 on Jun 13 ’25. In the deal valued at $13.13 per share,381 shares were bought. As a result of this transaction, Chard Daniel R now holds 149,698 shares worth roughly $2.05 million.
DA Davidson upgraded its Medifast Inc [MED] rating to a Neutral from a an Underperform in a research note published on November 05, 2024; the price target was increased to $17 from $16.50. A number of analysts have revised their coverage, including DA Davidson’s analysts, who decreased its forecast for the stock in early June from “a Neutral” to “an Underperform”. Stephens began covering MED with “an Equal-weight” recommendation on October 13, 2023. DA Davidson revised its rating on November 04, 2022. It rated MED as “a Neutral” which previously was an “a Buy”.
Price Performance Review of MED
On Tuesday, Medifast Inc [NYSE:MED] saw its stock fall -4.53% to $13.69. Over the last five days, the stock has lost -10.05%. Medifast Inc shares have fallen nearly -28.66% since the year began. Nevertheless, the stocks have fallen -22.30% over the past one year. While a 52-week high of $22.66 was reached on 01/02/25, a 52-week low of $11.57 was recorded on 04/21/25.
Levels Of Support And Resistance For MED Stock
The 24-hour chart illustrates a support level at 13.47, which if violated will result in even more drops to 13.26. On the upside, there is a resistance level at 14.12. A further resistance level may holdings at 14.56.
How much short interest is there in Medifast Inc?
A steep rise in short interest was recorded in Medifast Inc stocks on 2025-06-13, growing by 0.25 million shares to a total of 1.65 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 1.4 million shares. There was a rise of 15.09%, which implies that there is a positive sentiment for the stock.
